MA31692B1 - Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine - Google Patents

Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Info

Publication number
MA31692B1
MA31692B1 MA32671A MA32671A MA31692B1 MA 31692 B1 MA31692 B1 MA 31692B1 MA 32671 A MA32671 A MA 32671A MA 32671 A MA32671 A MA 32671A MA 31692 B1 MA31692 B1 MA 31692B1
Authority
MA
Morocco
Prior art keywords
benzoferanil
polymorphisms
amino methyl
carbonyl amino
carbonyl
Prior art date
Application number
MA32671A
Other languages
Arabic (ar)
English (en)
Inventor
Leanda Jane Kindon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA31692B1 publication Critical patent/MA31692B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines de (s)-2-((4-benzofuranyl)carbonylam
MA32671A 2007-09-13 2010-03-05 Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine MA31692B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0717882.5A GB0717882D0 (en) 2007-09-13 2007-09-13 Novel pharmaceutical
PCT/EP2008/062064 WO2009034133A1 (fr) 2007-09-13 2008-09-11 Formes polymorphes de (s)-2-((4-benzofuranyl)carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Publications (1)

Publication Number Publication Date
MA31692B1 true MA31692B1 (fr) 2010-09-01

Family

ID=38658914

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32671A MA31692B1 (fr) 2007-09-13 2010-03-05 Formes polymorphes de (s)-2-((4-benzofuranyl) carbonylaminométhyl)-1-((4-(2-méthyl-5-(4-fluorophényl)thiazolyl)carbonyl)pipéridine

Country Status (22)

Country Link
US (1) US20100286201A1 (fr)
EP (1) EP2190842A1 (fr)
JP (1) JP2010539133A (fr)
KR (1) KR20100057035A (fr)
CN (1) CN101801968A (fr)
AR (1) AR068414A1 (fr)
AU (1) AU2008297126A1 (fr)
BR (1) BRPI0816757A2 (fr)
CA (1) CA2699472A1 (fr)
CL (1) CL2008002688A1 (fr)
CO (1) CO6260068A2 (fr)
CR (1) CR11306A (fr)
DO (1) DOP2010000066A (fr)
EA (1) EA201070361A1 (fr)
GB (1) GB0717882D0 (fr)
MA (1) MA31692B1 (fr)
MX (1) MX2010002895A (fr)
PE (1) PE20090639A1 (fr)
TW (1) TW200927748A (fr)
UY (1) UY31337A1 (fr)
WO (1) WO2009034133A1 (fr)
ZA (1) ZA201001083B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101110A1 (en) * 2010-10-26 2012-04-26 Sangamesh Badiger Diaza-spiro[5.5]undecanes
WO2017194548A1 (fr) 2016-05-10 2017-11-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement de maladies inflammatoires auto-immunes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE293101T1 (de) * 2000-06-16 2005-04-15 Smithkline Beecham Plc Piperidine zur verwendung als orexin rezeptor antagonisten
US20060178307A1 (en) * 2005-01-26 2006-08-10 The Regents Of The University Of California Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor

Also Published As

Publication number Publication date
AR068414A1 (es) 2009-11-18
CO6260068A2 (es) 2011-03-22
CA2699472A1 (fr) 2009-03-19
PE20090639A1 (es) 2009-06-25
CL2008002688A1 (es) 2009-11-27
EP2190842A1 (fr) 2010-06-02
MX2010002895A (es) 2010-04-01
ZA201001083B (en) 2010-10-27
TW200927748A (en) 2009-07-01
CN101801968A (zh) 2010-08-11
DOP2010000066A (es) 2010-04-15
US20100286201A1 (en) 2010-11-11
GB0717882D0 (en) 2007-10-24
EA201070361A1 (ru) 2010-08-30
AU2008297126A1 (en) 2009-03-19
BRPI0816757A2 (pt) 2015-03-17
CR11306A (es) 2010-04-20
WO2009034133A1 (fr) 2009-03-19
UY31337A1 (es) 2009-04-30
JP2010539133A (ja) 2010-12-16
KR20100057035A (ko) 2010-05-28

Similar Documents

Publication Publication Date Title
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
ATE384039T1 (de) Indanderivate als muscarinrezeptoragonisten
MA31918B1 (fr) Agents et épitopes de liaison à wise
DK1919907T3 (da) Heterocyklisk forbindelse
ATE449761T1 (de) Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
EP1954683A4 (fr) 2-(phenyl ou heterocyclique)-1h-phenantrho(9,10-d)imidazoles utilisees comme inhibiteurs de la mpges-1
DE602006015607D1 (de) Thiazol-4-carboxamid-derivate als mglur5-antagonisten
ATE510832T1 (de) Heterocyclische verbindungen als c-fms- kinasehemmer
ATE463486T1 (de) Enantiomerenreine aminoheteroaryl-verbindungen als proteinkinasehemmer
ATE496029T1 (de) Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
ITBO20050696A1 (it) Macchina per la produzione di filtri composti
ATE512953T1 (de) Heterocyclische verbindungen
DE602006019624D1 (de) Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
ATE535523T1 (de) Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten
EA200800065A1 (ru) Аминокислые соли росиглитазона
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
MA32788B1 (fr) 1-(arylsulfonyl)-4-(piperazine-1-yl)-1h-benzimidazoles servant de ligands de la 5-hydroxytryptamine-6